Blackwell Kimberly

Related Filers (3)

Ownership (19)

4
Monday, 2/5/2024
Zentalis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 11/13/2023
Zentalis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/29/2023
Century Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/15/2023
Monte Rosa Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/1/2023
Zentalis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/16/2022
Monte Rosa Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/10/2022
Century Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 5/20/2022
Zentalis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/5/2022
Zentalis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 12/2/2021
Zentalis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/2/2021
Zentalis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 10/27/2021
Zentalis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/25/2021
Monte Rosa Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 6/23/2021
Monte Rosa Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Monday, 6/21/2021
Century Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 6/17/2021
Century Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 6/8/2021
Zentalis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 7/1/2020
Zentalis Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 7/1/2020
Zentalis Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
Show More